Virus-like Particle Vaccines and Platforms for Vaccine Development
Virus-like Particle Vaccines and Platforms for Vaccine Development
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use of VLP-based vaccines to protect against three infectious agents-hepatitis B virus, human papillomavirus, and hepatitis E virus-has been approved; they are very efficacious and offer long-lasting immune responses. Besides these, VLPs from other viral infe...
Alternative Titles
Full title
Virus-like Particle Vaccines and Platforms for Vaccine Development
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_09f0968f18354eafb8d98b05a7000ac9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_09f0968f18354eafb8d98b05a7000ac9
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v15051109
